Up-regulation of LncRNA UCA1 by TGF-β promotes doxorubicin resistance in breast cancer cells
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Up-regulation of LncRNA UCA1 by TGF-β promotes doxorubicin resistance in breast cancer cells
Authors
Keywords
-
Journal
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
Volume -, Issue -, Pages 1-8
Publisher
Informa UK Limited
Online
2022-03-25
DOI
10.1080/08923973.2022.2054428
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Upregulated UCA1 contributes to oxaliplatin resistance of hepatocellular carcinoma through inhibition of miR‐138‐5p and activation of AKT/mTOR signaling pathway
- (2021) Guolin Huang et al. Pharmacology Research & Perspectives
- Cancer drug resistance induced by EMT: novel therapeutic strategies
- (2021) Javier De Las Rivas et al. ARCHIVES OF TOXICOLOGY
- LncRNA UCA1 promotes development of gastric cancer via the miR-145/MYO6 axis
- (2021) An Yang et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Long Non-Coding RNA UCA1 Modulates Paclitaxel Resistance in Breast Cancer via miR-613/CDK12 Axis
- (2020) Chunhong Liu et al. Cancer Management and Research
- lncRNA UCA1 Contributes to 5-Fluorouracil Resistance of Colorectal Cancer Cells Through miR-23b-3p/ZNF281 Axis
- (2020) Zhenyu Xian et al. OncoTargets and Therapy
- LncRNA lnc-TSI Inhibits Metastasis of Clear Cell Renal Cell Carcinoma by Suppressing TGF-β-induced Epithelial-mesenchymal Transition
- (2020) Peng Wang et al. Molecular Therapy-Nucleic Acids
- Long non-coding RNAs MACC1-AS1 and FOXD2-AS1 mediate NSD2-induced cisplatin resistance in esophageal squamous cell carcinoma
- (2020) Wenhua Xue et al. Molecular Therapy-Nucleic Acids
- Long non-coding RNA UCA1 promotes breast cancer by upregulating PTP1B expression via inhibiting miR-206
- (2019) Yi Li et al. Cancer Cell International
- Exosome-Mediated Transfer of lncRNA HOTTIP Promotes Cisplatin Resistance in Gastric Cancer Cells by Regulating HMGA1/miR-218 Axis
- (2019) Jingyu Wang et al. OncoTargets and Therapy
- TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis
- (2018) Xiaodan Xu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- TGFβ1 Promotes Gemcitabine Resistance through Regulating the LncRNA-LET/NF90/miR-145 Signaling Axis in Bladder Cancer
- (2017) Junlong Zhuang et al. Theranostics
- LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression
- (2017) Zheng Fang et al. Cancer Medicine
- Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells
- (2016) Jingjing Pan et al. CANCER LETTERS
- TGF-β Signaling in Cancer
- (2016) Viqar Syed JOURNAL OF CELLULAR BIOCHEMISTRY
- Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
- (2016) Bowen Du et al. MOLECULES
- Epithelial–mesenchymal transition: a new target in anticancer drug discovery
- (2016) Fabrizio Marcucci et al. NATURE REVIEWS DRUG DISCOVERY
- Regulation of lncRNA and Its Role in Cancer Metastasis
- (2016) Juan Li et al. ONCOLOGY RESEARCH
- Genome-Wide Identification and Characterization of Novel Factors Conferring Resistance to Topoisomerase II Poisons in Cancer
- (2015) R. H. Wijdeven et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now